A pharmaceutical composition comprising the therapeutically effective amount of a compound of salts, compounds of formula (I) and a pharmaceutically acceptable. The compounds are useful in the treatment of psoriasis, cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic cardiomyopathy, atherosclerosis, and macular edema. [Selection] Figure Figure 1式(I)の化合物およびその医薬的に許容できる塩、ならびに療法有効量の該化合物を含む医薬組成物。該化合物は、癌、糖尿病性網膜障害、加齢性黄斑変性症、炎症、発作、虚血性心筋、アテローム性硬化症、黄斑浮腫および乾癬の処置に有用である。【選択図】図1